Clinical Trial

Impact of Incomplete Endometrial Ablation

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 12, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the proposed protocol is to study the impact of incomplete endometrial ablation on the PBAC score, reintervention, satisfaction, controlled bleeding and dysmenorrhea at 24 months after Novasure endometrial ablation, in women with heavy menstrual bleeding treated at Máxima Medical Centre Veldhoven, in The Netherlands.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-05; most recent amendment 2025-06-10.
Status change: Enrolling by Invitation → Active, Not Recruiting 2025-06-10
Trial Details
NCT Number NCT06122363
Lead Sponsor Maxima Medical Center
Conditions Heavy Menstrual Bleeding
Enrollment 121 participants
Start Date 2023-03-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-12